Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 13440
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.160nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.240nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.300nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.330nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.530nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.680nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 0.930nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.01nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.09nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.35nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.54nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.78nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.86nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 1.89nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.12nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.12nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.20nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.23nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.65nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.68nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.85nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 2.89nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 3.24nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info
TargetSodium channel protein type 8 subunit alpha(Human)
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Jiangsu Hengrui Pharmaceuticals Co.
US Patent
Affinity DataIC50: 5.30nMAssay Description:The c-Kit mutant D816V inhibitors were assessed using an engineered BaF3-FL KIT D816V or BaF3-FL KIT V560G/D816V cell line. The BaF3-FL KIT D816V cel...More data for this Ligand-Target Pair
Ligand Info























